Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122405912 | 12240591 | 2 | F | 201512 | 20160919 | 20160405 | 20160920 | PER | PHEH2016US008233 | NOVARTIS | 75.72 | YR | F | Y | 0.00000 | 20160920 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122405912 | 12240591 | 1 | PS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Oral | 75 MG, QD | 22291 | 75 | MG | QD | |||||||
| 122405912 | 12240591 | 2 | SS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Oral | 50 MG, QD | 22291 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122405912 | 12240591 | 1 | Immune thrombocytopenic purpura |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122405912 | 12240591 | Diarrhoea | |
| 122405912 | 12240591 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122405912 | 12240591 | 1 | 20150902 | 0 |